Search - tctmd.com

Displaying 1 - 10 of 10

Sort: Relevancy | Date

The finding, from a study with a mean follow-up of 2-and-a-half years, bolsters support for trials and device use to continue.

News Daily News

SWEDEPAD: No Mortality Signal With Paclitaxel in PAD

December 18, 2020

Longer Patency, Fewer Repeat Procedures With Paclitaxel DCBs in Dialysis Patients

News Daily News

Longer Patency, Fewer Repeat Procedures With Paclitaxel DCBs in Dialysis Patients

August 21, 2020

CV Prevention Meds Underused in Hispanic, Latinx PAD Patients

News Daily News

CV Prevention Meds Underused in Hispanic, Latinx PAD Patients

August 12, 2020

VOYAGER PAD: Rivaroxaban Bests Aspirin Alone for Preventing Limb and CV Events

News Conference News ACC 2020

VOYAGER PAD: Rivaroxaban Bests Aspirin Alone for Preventing Limb and CV Events

March 28, 2020

COVID-19 Poised to Upend the Cath Lab, ACC and SCAI Say

News Daily News

COVID-19 Poised to Upend the Cath Lab, ACC and SCAI Say

March 18, 2020

Ideal CV Health Over the Long Term Linked With Better Survival, Less Disease

News Daily News

Ideal CV Health Over the Long Term Linked With Better Survival, Less Disease

Michael O'Riordan

March 13, 2020

Values-Based Outpatient Care: Put Patients First Even When No One’s Watching

News Conference News ISET 2020

Values-Based Outpatient Care: Put Patients First Even When No One’s Watching

February 05, 2020

Common-Femoral Lesions: LINC 2020 Experts Hash Out the Best PAD Treatment

News Conference News LINC 2020

Common-Femoral Lesions: LINC 2020 Experts Hash Out the Best PAD Treatment

January 31, 2020

COMPARE: Similar Efficacy and Safety for Paclitaxel Balloons Regardless of Dose

News Conference News LINC 2020

COMPARE: Similar Efficacy and Safety for Paclitaxel Balloons Regardless of Dose

January 28, 2020

PAD Care on the Backdrop of Cancer Requires Creativity, Persistence

News Conference News ISET 2020

PAD Care on the Backdrop of Cancer Requires Creativity, Persistence

January 23, 2020

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.